Aoxing Pharmaceutical Company (AOXG) Financial Statements
Aoxing Pharmaceutical Company Financial Overview
Aoxing Pharmaceutical Company's market cap is currently $876.78K. The company's EPS TTM is $0.00; its P/E ratio is -37.50; Aoxing Pharmaceutical Company has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Q2 26 | Q1 26 | Q3 17 | Q2 17 | Q1 17 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 17.21K | $ 2.08K | $ 5.70M | $ 8.01M | $ 7.57M |
| Gross Profit | $ 17.00K | $ 0.00 | $ 4.42M | $ 6.30M | $ 6.05M |
| Operating Income | $ -11.20K | $ -2.44K | $ 878.40K | $ 233.20K | $ 1.70M |
| EBITDA | $ -11.20K | $ -2.44K | $ 1.12M | $ 502.70K | $ 1.95M |
| Net Income | $ -11.20K | $ -2.44K | $ 132.14K | $ -43.45K | $ 346.08K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 23.83K | $ 23.94K | $ 7.08M | $ 6.85M | $ 7.06M |
| Total Assets | $ 125.88K | $ 125.99K | $ 62.47M | $ 58.72M | $ 58.77M |
| Total Debt | $ 102.87K | $ 102.18K | $ 27.72M | $ 24.39M | $ 25.39M |
| Net Debt | $ 79.04K | $ 78.24K | $ 20.64M | $ 17.54M | $ 18.34M |
| Total Liabilities | $ 131.34K | $ 120.26K | $ 44.38M | $ 40.92M | $ 40.26M |
| Stockholders' Equity | $ -5.46K | $ 5.74K | $ 19.11M | $ 18.84M | $ 19.53M |
| Cash Flow | |||||
| Free Cash Flow | $ -800.00 | $ -104.39K | $ -3.02M | $ 81.29K | $ 132.81K |
| Operating Cash Flow | $ -801.00 | $ -104.39K | $ -3.02M | $ 87.94K | $ 134.94K |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ -80.00 | $ -6.64K | $ -2.13K |
| Financing Cash Flow | $ 689.00 | $ 102.18K | $ 3.18M | $ 0.00 | $ 0.00 |
Currency in USD